pharma · Retinitis Pigmentosa
GenSight Biologics
GenSight Biologics S.A.
GenSight Biologics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
paris, FR HQ
2013 Founded
34 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- paris, FR
- Founded
- 2013
- Employees
- 34
- Programs
- 2
- Drugs
- 2
- Patents
- 0
GenSight Biologics patents
0 pharmaceutical patents indexed for GenSight Biologics. 0 expire within 24 months.
GenSight Biologics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does GenSight Biologics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do GenSight Biologics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.